Cargando…
TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway
Prostate cancer is the fifth leading cause of cancer‐related deaths in males globally. Tripartite Motif Containing 66 (TRIM66) functions as transcriptional repressor and exerts its effect at least partially through promotion of deacetylase. TRIM66 has been previously reported to play an oncogenic ro...
Autores principales: | Cao, Hongwen, Gao, Renjie, Chen, Lei, Feng, Yigeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137797/ https://www.ncbi.nlm.nih.gov/pubmed/31981447 http://dx.doi.org/10.1002/2211-5463.12798 |
Ejemplares similares
-
Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis
por: Cao, Hongwen, et al.
Publicado: (2021) -
Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway
por: Cao, Hongwen, et al.
Publicado: (2023) -
QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo
por: Cao, Hongwen, et al.
Publicado: (2023) -
miR-143 mediates abiraterone acetate resistance by regulating the JNK/Bcl-2 signaling pathway in prostate cancer
por: Feng, Yigeng, et al.
Publicado: (2022) -
Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology
por: Cao, Hongwen, et al.
Publicado: (2022)